Skip to main content
. 2020 Apr 7;74(3):829–837. doi: 10.3233/JAD-191227

Table 1.

Demographic data of the clinical groups at baseline

Diagnosis AD dementia Amnestic MCI Healthy individuals
N 38 64 61
Gender female (%) 20 (52.6) 34 (53.1) 40 (65.6)
Age (y) 63.5 (54–78) 64 (53–79) 68 (53–79)
APOE ɛ4 allele (%) 30 (78.9) 39 (60.9) 20 (32.8)
MMSE (max. 30) 23 (16–27) 28 (23–30) 30 (28–30)
TMTA (s) 60 (32–300) 51 (23–146) 43 (23–75)
TMTB (s) 161 (107–255) 109 (72–330) 94 (40–240)
CERAD TWT, delayed recall 1 (0–5) 3 (0–8) 7 (3–10)

AD, Alzheimer’s disease; MCI, mild cognitive impairment; TMTA, Trailmaking test A; TMTB, Trailmaking test B; TWT, Ten Word Test. Age, MMSE, TMTA, TMTB, and CERAD TWT delayed recall are given as median (range).